HIGHLIGHTS
- who: Maria Francesca Santolla from the Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy have published the article: miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling, in the Journal: (JOURNAL)
- what: The authors investigated the involvement of miR-221 in Methods: TaqMan microRNA assay was used to detect the miR-221 levels in normal cells and in MDA-MB 231 and SkBr3 cells as well as in main players of the tumor microenvironment namely cancer-associated fibroblasts (CAFs). miR . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.